Effectiveness of seasonal influenza vaccinations against laboratory-confirmed influenza-associated infections among Singapore military personnel in 2010-2013

被引:12
作者
Ho, Hin Peow [1 ]
Zhao, Xiahong [2 ,3 ]
Pang, Junxiong [2 ]
Chen, Mark I. -C. [2 ,4 ]
Lee, Vernon J. M. [1 ]
Ang, Li Wei [5 ]
Lin, Raymond V. Tzer Pin [6 ]
Gao, Christine Q. [1 ]
Hsu, Li Yang [2 ]
Cook, Alex R. [2 ,7 ]
机构
[1] Minist Def, Biodefence Ctr, Singapore, Singapore
[2] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Ctr Infect Dis Epidemiol & Res, Singapore 117597, Singapore
[3] Natl Univ Hlth Syst, Singapore, Singapore
[4] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore
[5] Minist Hlth, Epidemiol & Dis Control Div, Singapore, Singapore
[6] Minist Hlth, Natl Publ Hlth Lab, Singapore, Singapore
[7] Natl Univ Singapore, Yale NUS Coll, Singapore 117597, Singapore
关键词
influenza A(H1N1)pdm09; influenza A(H3N2); influenza B; influenza vaccination; vaccine effectiveness; VACCINE EFFECTIVENESS; DIAGNOSIS;
D O I
10.1111/irv.12256
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundLimited information is available about seasonal influenza vaccine effectiveness (VE) in tropical communities. ObjectivesVirus subtype-specific VE was determined for all military service personnel in the recruit camp and three other non-recruit camp in Singapore's Armed Forces from 1 June 2009 to 30 June 2012. MethodsConsenting servicemen underwent nasal washes, which were tested with RT-PCR and subtyped. The test positive case and test negative control design was used to estimate the VE. To estimate the overall effect of the programme on new recruits, we used an ecological time series approach. ResultsA total of 7016 consultations were collected. The crude estimates for the VE of the triavalent vaccine against both influenza A(H1N1)pdm09 and influenza B were 84% (95% CI 78-88%, 79-86%, respectively). Vaccine efficacy against influenza A(H3N2) was markedly lower (VE 33%, 95% CI -4% to 57%). An estimated 70% (RR=030; 95% CI 011-084), 39% (RR=061;025-143) and 75% (RR=025; 95% CI 011-050) reduction in the risk of influenza A(H1N1)pdm09, influenza A(H3N2) and influenza B infections, respectively, in the recruit camp during the post-vaccination period compared with during the pre-vaccination period was observed. ConclusionsOverall, the blanket influenza vaccine programme in Singapore's Armed Forces has had a moderate to high degree of protection against influenza A(H1N1)pdm09 and influenza B, but not against influenza A(H3N2). Blanket influenza vaccination is recommended for all military personnel.
引用
收藏
页码:557 / 566
页数:10
相关论文
共 22 条
  • [1] [Anonymous], 2010, EURO SURVEILL
  • [2] [Anonymous], 2010, US MORB MORT WEEKL R
  • [3] [Anonymous], 2012, R LANG ENV STAT COMP
  • [4] Protection against influenza after annually repeated vaccination -: A meta-analysis of serologic and field studies
    Beyer, WEP
    de Bruijn, IA
    Palache, AM
    Westendorp, RGJ
    Osterhaus, ADME
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (02) : 182 - 188
  • [5] Bonmarin I, 2012, EUROSURVEILLANCE, V17, P17
  • [6] Influenza vaccine: The challenge of antigenic drift
    Carrat, F.
    Flahault, A.
    [J]. VACCINE, 2007, 25 (39-40) : 6852 - 6862
  • [7] Fielding J, 2012, EURO SURVEILL, V17, P20115
  • [8] Behaviour and control of influenza in institutions and small societies
    Finnie, Thomas James Ronald
    Hall, Ian M.
    Leach, Steve
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2012, 105 (02) : 66 - 73
  • [9] The annual production cycle for influenza vaccine
    Gerdil, C
    [J]. VACCINE, 2003, 21 (16) : 1776 - 1779
  • [10] Seasonal Influenza in Adults and Children-Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America
    Harper, Scott A.
    Bradley, John S.
    Englund, Janet A.
    File, Thomas M.
    Gravenstein, Stefan
    Hayden, Frederick G.
    McGeer, Allison J.
    Neuzil, Kathleen M.
    Pavia, Andrew T.
    Tapper, Michael L.
    Uyeki, Timothy M.
    Zimmerman, Richard K.
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (08) : 1003 - 1032